4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-121881
CIK 0001660719operating
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:31 PM ET
Size
4.9 KB
Accession
0001104659-16-121881
Insider Transaction Report
Form 4
Glickman Mark A
Chief Commercial Officer
Transactions
- Purchase
Common Shares, without par value
2016-05-16$3.68/sh+25,000$92,050→ 186,553 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $3.64 to $3.72, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:31 PM ET
- Size
- 4.9 KB